LH
35
3
AON
45
4
ISRG
54
6
DOV
52
4
CFG
20
6
BBBY
36
3
AIV
60
5
PPG
53
4
VLO
55
3
NI
62
12
KHC
54
7
CAG
72
2
KR
56
3
ADT
37
4
HON
52
2
CAH
37
6
GRMN
45
2
CME
45
5
VTR
41
3
RHI
33
3
LH
35
3
AON
45
4
ISRG
54
6
DOV
52
4
CFG
20
6
BBBY
36
3
AIV
60
5
PPG
53
4
VLO
55
3
NI
62
12
KHC
54
7
CAG
72
2
KR
56
3
ADT
37
4
HON
52
2
CAH
37
6
GRMN
45
2
CME
45
5
VTR
41
3
RHI
33
3
Financhill
Back

ITeos Therapeutics 10K Form

Sell
19

ITOS
ITeos Therapeutics

Last Price:
13.63
Seasonality Move:
-43.16%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive ITOS News And Ratings

See the #1 stock for the next 7 days that we like better than ITOS

ITOS Financial Statistics

Sales & Book Value

Annual Sales: $267.63M
Cash Flow: $-27.29M
Price / Cash Flow: 0
Annual Sales: $18.63
Price / Book: 0.73

Profitability

EPS (TTM): 2.55000
Net Income (TTM): $96.65M
Gross Margin: --
Return on Equity: 15.52%
Return on Assets: 11.84%

ITeos Therapeutics Earnings Forecast

Key ITeos Therapeutics Financial Ratios

  • The Research & Development expenses have been 36.38% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • Per Share Earnings over the last 5 years have been positive in 1 years.

ITeos Therapeutics Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Healthcare
Current Symbol: ITOS
CUSIP: 46565G
Website: iteostherapeutics.com

Debt

Debt-to-Equity Ratio: 0
Current Ratio: 14.96
Quick Ratio: 14.66

Price-to-Earnings

Trailing P/E Ratio: 5.32
Forward P/E Ratio: 0

ITOS Technical Analysis vs Fundamental Analysis

Sell
19
ITeos Therapeutics (ITOS) is a Sell

Is ITeos Therapeutics a Buy or a Sell?